V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008757 | 280005982 | 1.78 | 92 | Curative (C) | 2014-01-04 | 2014-01-04 | VAI (Ifos 3g/m2) | 2 | null | 280028706 | IRINOTECAN + MDG |
| 280008758 | 280005985 | 1.84 | 71 | Palliative (P) | 2016-12-10 | 2016-12-28 | Doxorubicin + Ifosfamide | N | N | 280028715 | DOXORUBICIN + IFOSFAMIDE |
| 280008759 | 280005985 | null | 57 | Not known (9) | 2013-05-31 | 2013-05-31 | DE-ESCALATE TRIAL | N | N | 280028715 | DE-ESCALATE TRIAL |
| 280008760 | 280005985 | 1.67 | 58.75 | Curative (C) | 2017-01-14 | 2017-01-16 | Doxorubicin + Ifosfamide | 02 | N | 280028715 | DOXORUBICIN + IFOSFAMIDE |
| 280008761 | 280005985 | null | 76 | Curative (C) | 2018-03-24 | 2018-03-24 | CISPLATIN + FLUOROURACIL | 02 | N | 280028715 | CISPLATIN + FLUOROURACIL |
| 280008762 | 280005986 | null | 92.2 | Curative (C) | 2015-04-17 | 2015-04-23 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 280028735 | CISPLATIN + GEMCITABINE |
| 280008763 | 280005987 | 1.7 | 81 | Curative (C) | 2017-09-06 | 2017-09-13 | Carboplatin 21day + Paclitaxel 7day | 2 | N | 280028736 | CARBOPLATIN + PACLITAXEL |
| 280008764 | 280005989 | 1.6 | 52 | Palliative (P) | 2013-10-27 | 2014-04-21 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280028739 | CARBOPLATIN + PACLITAXEL |
| 280008765 | 280005991 | 1.72 | 94 | Palliative (P) | 2017-01-16 | 2017-01-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 280028744 | CISPLATIN + GEMCITABINE |
| 280008766 | 280005992 | 1.75 | 93.4 | Palliative (P) | 2015-07-05 | 2015-07-06 | EURO-EWING | null | N | 280028746 | EURO-EWING |
| 280008767 | 280009137 | null | 69.7 | Palliative (P) | 2016-08-26 | 2016-09-16 | Doxorubicin + Olaratumab | 2 | N | 280028748 | DOXORUBICIN + OLARATUMAB |
| 280008768 | 280005994 | null | null | null | 2013-04-24 | 2013-04-24 | CISPLATIN + FLUOROURACIL | N | N | 280028749 | CISPLATIN + FLUOROURACIL |
| 280008769 | 280005995 | 1.63 | 61.6 | Adjuvant (A) | 2014-11-15 | 2015-01-04 | EW EuroEwing 99 : VActI | null | Y | 280028760 | EURO-EWING |
| 280008770 | 280005997 | 1.73 | null | null | null | 2018-05-16 | Cyclophosphamide oral | null | null | 280028764 | CYCLOPHOSPHAMIDE |
| 280008771 | 280010651 | 1.74 | 111 | Curative (C) | 2015-03-28 | 2015-07-02 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 280028765 | CISPLATIN + GEMCITABINE |
| 280008772 | 280010651 | 1.66 | 71.25 | Adjuvant (A) | 2015-07-14 | 2015-08-02 | VAC | 02 | null | 280028765 | CAV |
| 280008773 | 280006000 | 1.65 | 62.2 | null | 2017-01-01 | 2017-05-27 | EW Rel rEECur Irinotecan/Temozolomide | N | null | 280028766 | IRINOTECAN + MDG |
| 280008774 | 280006000 | 1.73 | 80 | Palliative (P) | 2016-03-10 | 2016-03-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028766 | CISPLATIN + GEMCITABINE |
| 280008775 | 280006001 | null | null | Curative (C) | 2018-01-02 | 2018-06-11 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280028773 | CARBOPLATIN + PACLITAXEL |
| 280008776 | 280006002 | 1.56 | 84.6 | Palliative (P) | 2017-01-23 | 2017-09-26 | Etoposide + Ifosfamide (5 days) | N | N | 280028776 | ETOPOSIDE + IFOSFAMIDE |
| 280008777 | 280006003 | 1.7 | 98 | Curative (C) | 2016-01-11 | 2016-01-11 | GEMCITABINE | 02 | N | 280028780 | GEMCITABINE |
| 280008778 | 280006003 | 1.66 | 76.4 | Palliative (P) | 2014-07-08 | 2014-07-10 | Etoposide + Ifosfamide (3 days) | N | N | 280028780 | ETOPOSIDE + IFOSFAMIDE |
| 280008779 | 280006004 | 1.7 | null | Palliative (P) | 2016-10-12 | 2016-10-12 | EURO-EWING | Y | N | 280028794 | EURO-EWING |
| 280008780 | 280006007 | 1.73 | 104 | Palliative (P) | 2015-12-24 | 2015-12-24 | Doxorubicin + Ifosfamide | N | N | 280028797 | DOXORUBICIN + IFOSFAMIDE |
| 280008781 | 280006008 | 1.71 | 81 | Palliative (P) | null | 2016-12-30 | CISPLATIN + FLUOROURACIL | 02 | N | 280028798 | CISPLATIN + FLUOROURACIL |
| 280008782 | 280006009 | 1.86 | null | Palliative (P) | 2014-08-11 | 2014-08-11 | Etoposide + Ifosfamide (3 days) | N | N | 280028798 | ETOPOSIDE + IFOSFAMIDE |
| 280008783 | 280011389 | 1.79 | 117.4 | Palliative (P) | 2016-06-04 | 2016-06-05 | Etoposide + Ifosfamide (3 days) | 02 | N | 280028808 | ETOPOSIDE + IFOSFAMIDE |
| 280008784 | 280011389 | 1.71 | 60.4 | Palliative (P) | 2014-10-14 | 2014-11-23 | CISPLATIN + GEMCITABINE | N | null | 280028808 | CISPLATIN + GEMCITABINE |
| 280008785 | 280006012 | 1.83 | 82.4 | Palliative (P) | 2014-02-11 | 2014-02-16 | Irinotecan + Temozolomide | 02 | N | 280028814 | IRINOTECAN + MDG |
| 280008786 | 280006013 | 1.61 | 52.9 | Palliative (P) | 2014-02-18 | 2014-02-25 | Irinotecan + Temozolomide | 2 | N | 280028817 | VAI |
| 280008787 | 280006014 | 1.67 | 55.5 | Adjuvant (A) | 2016-05-08 | 2016-05-12 | Oxaliplatin + Modified de Gramont | N | N | 280028817 | OXALIPLATIN + MDG |
| 280008788 | 280006014 | 1.73 | 57 | Neo-adjuvant (N) | 2017-10-17 | 2017-10-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028817 | CISPLATIN + GEMCITABINE |
| 280008789 | 280006015 | 1.77 | 106 | Palliative (P) | 2016-12-30 | 2017-06-12 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028834 | CETUXIMAB + CISPLATIN + FU |
| 280008790 | 280006017 | 1.7 | 57.9 | Palliative (P) | 2016-12-28 | 2017-01-01 | CISPLATIN + FLUOROURACIL | N | N | 280028836 | CISPLATIN + FLUOROURACIL |
| 280008791 | 280006019 | 1.64 | 70 | Palliative (P) | 2013-07-07 | 2013-07-22 | CISPLATIN + FLUOROURACIL | 02 | N | 280028844 | CISPLATIN + FLUOROURACIL |
| 280008792 | 280009149 | 1.75 | 68.4 | Adjuvant (A) | 2014-11-21 | 2014-11-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 280028851 | CISPLATIN + GEMCITABINE |
| 280008793 | 280009151 | 1.66 | null | Adjuvant (A) | 2015-04-29 | 2015-05-02 | Oxaliplatin + Modified de Gramont | null | null | 280028855 | OXALIPLATIN + MDG |
| 280008794 | 280006023 | 1.75 | 62.4 | Palliative (P) | 2015-08-13 | 2015-08-19 | VAI (Ifos 3g/m2) | N | N | 280028857 | IRINOTECAN + TEMOZOLOMIDE |
| 280008795 | 280006024 | null | 88 | Palliative (P) | null | 2017-03-20 | CETUXIMAB + CISPLATIN + FU | N | N | 280028860 | CETUXIMAB + CISPLATIN + FU |
| 280008796 | 280006028 | 1.66 | null | Palliative (P) | 2017-04-28 | 2017-06-18 | VAC | N | N | 280028863 | CAV |
| 280008797 | 280006030 | 1.66 | null | Palliative (P) | 2010-06-21 | 2013-08-21 | Doxorubicin + Olaratumab | N | N | 280028864 | DOXORUBICIN + OLARATUMAB |
| 280008798 | 280006032 | 1.8 | 82.4 | Palliative (P) | 2013-09-03 | 2013-09-23 | Irinotecan + Modified De Gramont | N | N | 280028864 | IRINOTECAN + TEMOZOLOMIDE |
| 280008799 | 280006034 | null | 67 | Palliative (P) | 2013-11-27 | 2014-04-15 | CISPLATIN + FLUOROURACIL | Y | N | 280028868 | CISPLATIN + FLUOROURACIL |
| 280008800 | 280006034 | 1.7 | 102.7 | Neo-adjuvant (N) | 2017-07-28 | 2017-09-10 | DE-ESCALATE TRIAL | N | null | 280028868 | DE-ESCALATE TRIAL |
| 280008801 | 280006037 | 1.7 | null | Curative (C) | 2014-05-06 | 2014-05-11 | Carboplatin + Etoposide IV 3 day | N | N | 280028880 | CARBOPLATIN + ETOPOSIDE |
| 280008802 | 280010659 | 1.81 | 82.3 | Palliative (P) | 2015-11-25 | 2015-11-26 | Cetuximab +Cisplatin + FU (Cycle 1) | Y | N | 280028885 | CETUXIMAB + CISPLATIN + FU |
| 280008803 | 280010659 | 1.85 | 96.3 | Palliative (P) | 2015-03-27 | 2015-05-30 | CARBOPLATIN + PACLITAXEL | N | N | 280028885 | CARBOPLATIN + PACLITAXEL |
| 280008804 | 280010659 | null | 84.5 | Curative (C) | 2016-11-08 | 2016-12-29 | Oxaliplatin + Modified de Gramont | N | N | 280028885 | OXALIPLATIN + MDG |
| 280008805 | 280010659 | null | 77.8 | Palliative (P) | null | 2017-10-28 | CISPLATIN + FLUOROURACIL | N | N | 280028885 | CISPLATIN + FLUOROURACIL |
| 280008806 | 280006038 | null | 70.7 | Curative (C) | 2017-02-16 | 2017-05-10 | Doxorubicin + Ifosfamide | N | N | 280028918 | DOXORUBICIN + IFOSFAMIDE |